Use of annexin v as a method to block tumor induced immunosuppression of the innate immune response

A method of increasing the immune response to a tumor in an individual with cancer, the method comprising:

• administering a course of therapy to the individual by parenteral administration of an effective dose of an annexin V agent,
• wherein the annexin V agent is an annexin V protein that binds to phosphatidylserine (PS) and which comprises an amino sequence which has at least 95% sequence identity to the amino acid sequence of human annexin V protein, and
• wherein the individual also receives another cancer treatment modality.